AHMED NADIM — SEC Form 4 filings
SEC reporting owner CIK 1731193. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-23 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 60,747 shares, $724,571 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 16,381 shares @ $13.62 ($223,109) in Cullinan Therapeutics, Inc., filed 2026-02-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | President and CEO, Director | 8 | — | 5 legs · 60,747 sh · $724,571 | 5 |
| Disc Medicine, Inc. (IRON) | Director | 2 | — | — | 2 |
Form 4 filings — AHMED NADIM
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 5,176 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 13,515 @ $14.47 | EDGAR |
| 2026-02-23 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 16,381 @ $13.62 | EDGAR |
| 2026-02-19 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 828,000 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 9,922 @ $10.01 | EDGAR |
| 2025-07-16 | 4 | Disc Medicine, Inc. (IRON) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 12,529 @ $8.53 | EDGAR |
| 2025-02-21 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 180,000 @ $0 · Grant/award (A): 360,000 (derivative) @ $0 | EDGAR |
| 2024-12-27 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 8,400 @ $11.87 | EDGAR |
| 2024-02-23 | 4 | Cullinan Oncology, Inc. (CGEM) | Grant/award (A): 160,000 @ $0 · Grant/award (A): 320,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1731193 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →